Thursday, June 26, 2025 6/26/2025

Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT)

Award Number: R44HD090817
ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/15/2017
PERIOD OF PERFORMANCE END DATE: 07/31/2021

Group Awards By:

View Award Description

Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT) - PROJECT SUMMARY Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to TBI The goal of this Phase II SBIR project is to develop a rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT). About 30% TBI patients develop NCDT, a serious chronic disease. Standard NCDT diagnosis is based a battery of neuropsychological tests administered in hospital. Weaknesses of the standard practice: not objective, low accuracy, high cost and inconvenience. The proposed project will develop rapid commercial test for NCDT diagnostics in point-of-care (POC). The commercial test will be a disposable lateral flow immunoassay (LFIA) based on innovative technologies: 1/ Saliva-based NCDT biomarkers and 2 / Multiplexed LFIA for whole saliva. Key advantages over standard practice: objective, accurate, simple and inexpensive NCDT test. Phase I R&D identified N=15 candidate NCDT biomarkers with diagnostic accuracy ≥80% for NCDT, independent predictors, baseline concentration >10 ng/ml and fold increase in NCDT ≥5-fold. Specific objectives for Phase II: SA1 will collect N=2,610 longitudinal saliva samples from N=500 patients in a multi-center study: N=120 NCDT and N=380 controls. SA2 will measure 15 candidate NCDT biomarkers in saliva samples from SA1 using 3 gold standard saliva assays validated in Phase I. Results will cross-validate the diagnostic accuracy of the biomarkers, and down select 3 best biomarkers for the commercial NCDT test. SA3 will develop a prototype commercial LFIA test for measuring 3 NCDT biomarkers in whole saliva. The proposed NCDT test has potential to radically change standard practice in TBI care by providing valid, objective NCDT diagnostics, a key element for decisions about return to play, starting intervention, and for advancing TBI treatment. The proposed project has strong commercial potential based on existing team of proven industry partners and tested FDA regulatory path for the commercial device.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2018	GAIA MEDICAL INSTITUTE, LLC, THE	505 COAST BLVD SOUTH, STE 104	LA JOLLA	CA	92037	SAN DIEGO	USA	Child Health and Human Development Extramural Research	000	2	10/28/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2020 ( Subtotal = $0 )
2020	2018	GAIA MEDICAL INSTITUTE, LLC, THE	505 COAST BLVD SOUTH, STE 104	LA JOLLA	CA	92037	SAN DIEGO	USA	Child Health and Human Development Extramural Research	000	2	7/29/2020	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2018 ( Subtotal = $736,575 )
2018	2018	GAIA MEDICAL INSTITUTE, LLC, THE	505 COAST BLVD SOUTH, STE 104	LA JOLLA	CA	92037	SAN DIEGO	USA	Child Health and Human Development Extramural Research	000	2	7/19/2018	NON-COMPETING CONTINUATION	$736,575
														Subtotal = $736,575

Issue Date FY: 2017 ( Subtotal = $708,335 )
2017	2017	GAIA MEDICAL INSTITUTE, LLC, THE	505 COAST BLVD SOUTH, STE 104	LA JOLLA	CA	92037	SAN DIEGO	USA	Child Health and Human Development Extramural Research	000	1	8/11/2017	NEW	$708,335
														Subtotal = $708,335

Grand Total All Awards = $1,444,910

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT)

Award Number: R44HD090817

ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/15/2017

PERIOD OF PERFORMANCE END DATE: 07/31/2021

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer